BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31179768)

  • 1. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
    Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
    Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting NSG Mice Engrafting Cells with a Clinically Applicable Lentiviral Vector Corrects Osteoclasts in Infantile Malignant Osteopetrosis.
    Moscatelli I; Löfvall H; Schneider Thudium C; Rothe M; Montano C; Kertész Z; Sirin M; Schulz A; Schambach A; Henriksen K; Richter J
    Hum Gene Ther; 2018 Aug; 29(8):938-949. PubMed ID: 28726516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis.
    Moscatelli I; Thudium CS; Flores C; Schulz A; Askmyr M; Gudmann NS; Andersen NM; Porras O; Karsdal MA; Villa A; Fasth A; Henriksen K; Richter J
    Bone; 2013 Nov; 57(1):1-9. PubMed ID: 23907031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice.
    Johansson MK; de Vries TJ; Schoenmaker T; Ehinger M; Brun AC; Fasth A; Karlsson S; Everts V; Richter J
    Blood; 2007 Jun; 109(12):5178-85. PubMed ID: 17332244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells.
    Xian X; Moraghebi R; Löfvall H; Fasth A; Henriksen K; Richter J; Woods NB; Moscatelli I
    Stem Cell Res Ther; 2020 May; 11(1):179. PubMed ID: 32414402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene Therapy.
    Thudium CS; Moscatelli I; Löfvall H; Kertész Z; Montano C; Bjurström CF; Karsdal MA; Schulz A; Richter J; Henriksen K
    Calcif Tissue Int; 2016 Dec; 99(6):638-648. PubMed ID: 27541021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.
    Capo V; Penna S; Merelli I; Barcella M; Scala S; Basso-Ricci L; Draghici E; Palagano E; Zonari E; Desantis G; Uva P; Cusano R; Sergi Sergi L; Crisafulli L; Moshous D; Stepensky P; Drabko K; Kaya Z; Unal E; Gezdirici A; Menna G; Serafini M; Aiuti A; Locatelli SL; Carlo-Stella C; Schulz AS; Ficara F; Sobacchi C; Gentner B; Villa A
    Haematologica; 2021 Jan; 106(1):74-86. PubMed ID: 31949009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse.
    Tondelli B; Blair HC; Guerrini M; Patrene KD; Cassani B; Vezzoni P; Lucchini F
    Am J Pathol; 2009 Mar; 174(3):727-35. PubMed ID: 19218349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis.
    Askmyr M; Holmberg J; Flores C; Ehinger M; Hjalt T; Richter J
    Exp Hematol; 2009 Feb; 37(2):302-8. PubMed ID: 19100677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
    Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
    Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis.
    Johansson M; Jansson L; Ehinger M; Fasth A; Karlsson S; Richter J
    Exp Hematol; 2006 Feb; 34(2):242-9. PubMed ID: 16459192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis.
    Chen W; Twaroski K; Eide C; Riddle MJ; Orchard PJ; Tolar J
    J Bone Joint Surg Am; 2019 Nov; 101(21):1939-1947. PubMed ID: 31567691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonablative neonatal bone marrow transplantation rapidly reverses severe murine osteopetrosis despite low-level engraftment and lack of selective expansion of the osteoclastic lineage.
    Flores C; de Vries TJ; Moscatelli I; Askmyr M; Schoenmaker T; Langenbach GE; Ehinger M; Everts V; Richter J
    J Bone Miner Res; 2010 Sep; 25(9):2069-77. PubMed ID: 20568230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts.
    Neri T; Muggeo S; Paulis M; Caldana ME; Crisafulli L; Strina D; Focarelli ML; Faggioli F; Recordati C; Scaramuzza S; Scanziani E; Mantero S; Buracchi C; Sobacchi C; Lombardo A; Naldini L; Vezzoni P; Villa A; Ficara F
    Stem Cell Reports; 2015 Oct; 5(4):558-68. PubMed ID: 26344905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast rich osteopetrosis due to defects in the TCIRG1 gene.
    Capo V; Abinun M; Villa A
    Bone; 2022 Dec; 165():116519. PubMed ID: 35981697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis.
    Zirngibl RA; Wang A; Yao Y; Manolson MF; Krueger J; Dupuis L; Mendoza-Londono R; Voronov I
    J Cell Biochem; 2019 Oct; 120(10):17180-17193. PubMed ID: 31111556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations of TCIRG1 cause a malignant and mild phenotype of autosomal recessive osteopetrosis (ARO) in four Chinese families.
    Zhang XY; He JW; Fu WZ; Wang C; Zhang ZL
    Acta Pharmacol Sin; 2017 Nov; 38(11):1456-1465. PubMed ID: 28816234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis.
    Cappariello A; Berardi AC; Peruzzi B; Del Fattore A; Ugazio A; Bottazzo GF; Teti A
    J Bone Miner Res; 2010 Jan; 25(1):106-13. PubMed ID: 20091929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast morphology in autosomal recessive malignant osteopetrosis due to a TCIRG1 gene mutation.
    Bruder E; Stallmach T; Peier K; Superti-Furga A; Vezzoni P
    Pediatr Pathol Mol Med; 2003; 22(1):3-9. PubMed ID: 12687885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.